These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37540701)

  • 21. Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates.
    Yin D; Dong D; Li K; Zhang L; Liang J; Yang Y; Wu N; Bao Y; Wang C; Hu F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest.
    Nana T; Perovic O; Chibabhai V
    Clin Microbiol Infect; 2022 Dec; 28(12):1650.e1-1650.e5. PubMed ID: 35811020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].
    Tekintaş Y; Çilli F; Eraç B; Yaşar M; Aydemir SŞ; Hoşgör Limoncu M
    Mikrobiyol Bul; 2017 Jul; 51(3):269-276. PubMed ID: 28929963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Isolates Associated with Emergence of OXA-48-Producing Klebsiella pneumoniae in Croatia.
    Jelić M; Škrlin J; Bejuk D; Košćak I; Butić I; Gužvinec M; Tambić-Andrašević A
    Microb Drug Resist; 2018 Sep; 24(7):973-979. PubMed ID: 29267137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
    Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
    BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal.
    Thapa S; Adhikari N; Shah AK; Lamichhane I; Dhungel B; Shrestha UT; Adhikari B; Banjara MR; Ghimire P; Rijal KR
    Chemotherapy; 2021; 66(5-6):199-209. PubMed ID: 34515078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and Epidemiological Characteristics of Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates in Japan.
    Yonekawa S; Mizuno T; Nakano R; Nakano A; Suzuki Y; Asada T; Ishii A; Kakuta N; Tsubaki K; Mizuno S; Ogawa M; Yano H; Kasahara K; Mikasa K
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina.
    Nicola F; Cejas D; González-Espinosa F; Relloso S; Herrera F; Bonvehí P; Smayevsky J; Figueroa-Espinosa R; Gutkind G; Radice M
    Microbiol Spectr; 2022 Dec; 10(6):e0373322. PubMed ID: 36445147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity and carbapenem re-sensitizing ability of 1,10-phenanthroline-5,6-dione and its metal complexes against KPC-producing Klebsiella pneumoniae clinical strains.
    Vianez Peregrino I; Ferreira Ventura R; Borghi M; Pinto Schuenck R; Devereux M; McCann M; Souza Dos Santos AL; FerreiraNunes AP
    Lett Appl Microbiol; 2021 Aug; 73(2):139-148. PubMed ID: 33843058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae.
    López-Camacho E; Paño-Pardo JR; Sotillo A; Elías-López C; Martínez-Martínez L; Gómez-Gil R; Mingorance J
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):162-166. PubMed ID: 30297092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predominance of Klebsiella pneumoniae carbapenemase (KPC-type) gene among high-level carbapenem-resistant Klebsiella pneumoniae isolates in Baghdad, Iraq.
    Hussein NH; Mohammed Kareem S; Hussein Al-Kakei SN; Taha BM
    Mol Biol Rep; 2022 Jun; 49(6):4653-4658. PubMed ID: 35471622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020.
    Lee YL; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2022; 60(5-6):106679. PubMed ID: 36241011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.
    Beshah D; Desta AF; Woldemichael GB; Belachew EB; Derese SG; Zelelie TZ; Desalegn Z; Tessema TS; Gebreselasie S; Abebe T
    PLoS One; 2023; 18(6):e0287453. PubMed ID: 37368908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
    Erdem F; Díez-Aguilar M; Oksuz L; Kayacan C; Abulaila A; Oncul O; Morosini MI; Cantón R; Aktas Z
    Acta Microbiol Immunol Hung; 2022 Sep; 69(3):215-219. PubMed ID: 35895557
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain.
    Oteo J; Hernández JM; Espasa M; Fleites A; Sáez D; Bautista V; Pérez-Vázquez M; Fernández-García MD; Delgado-Iribarren A; Sánchez-Romero I; García-Picazo L; Miguel MD; Solís S; Aznar E; Trujillo G; Mediavilla C; Fontanals D; Rojo S; Vindel A; Campos J
    J Antimicrob Chemother; 2013 Feb; 68(2):317-21. PubMed ID: 23034714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem.
    Wang ZQ; Guo ZL; Feng H; Fu C; Zhao GY; Ma K; Zhu L; Chen G
    Curr Med Sci; 2021 Aug; 41(4):770-776. PubMed ID: 34403102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.